Medically reviewed by H. Andrew Hansen II, MD, MBA, FACS, FSVS, FACC, FAVLS
Cancer can affect the body in ways that go beyond the tumor itself. Changes in circulation, treatment, surgery, and activity levels can all influence a patient’s overall health and may create complications that need close attention. One concern is the formation of blood clots in the deep veins.
In this blog, Dr. H. Andrew Hansen, lead physician at Center for Vein Restoration (CVR) vein clinics in Houston, Texas, and The Woodlands, Texas, explains why cancer raises the risk of deep vein thrombosis (DVT), which symptoms need attention, how doctors prevent and treat blood clots, and when to seek urgent care.
If you’re undergoing cancer treatment and develop leg swelling, pain, warmth, or other possible DVT symptoms, schedule an evaluation with CVR. A board-certified vein specialist can assess your symptoms and help determine the safest next step while coordinating with your oncology team.
Schedule a consultation with Center for Vein Restoration (CVR) to receive prompt, expert evaluation in a safe outpatient setting.
Deep vein thrombosis occurs when a blood clot forms in a vein deep inside the body. DVT most often affects the lower leg, thigh, or pelvis, although it can also develop in an arm.
A clot may block blood flow through the affected vein. The most serious complication occurs when part of the clot breaks free and travels to the lungs, Mayo Clinic explains. This is a pulmonary embolism (PE), which can interfere with breathing and circulation and may be life-threatening. The U.S. Centers for Disease Control and Prevention advises immediate medical care for possible PE symptoms such as sudden shortness of breath or rapid heartbeat.
Cancer can make the blood more likely to clot, while cancer treatments, surgery, hospitalization, and reduced movement can add to that risk. Together, these factors make venous thromboembolism (VTE), which includes DVT and pulmonary embolism, an important concern during cancer care. Risk varies by cancer type, treatment, and individual health history. WebMD explains:
“The link between cancer and a type of blood clot called deep vein thrombosis (DVT) is a two-way street. If you have cancer, you have a bigger chance of getting DVT. And if you had DVT, your odds go up of getting diagnosed with cancer.”
WebMD
DVT doesn’t always cause obvious symptoms. When symptoms of DVT do occur, they usually affect one limb.
Possible signs include:
These symptoms can have other causes, so testing is needed to confirm DVT.
Sudden shortness of breath, chest pain that worsens with breathing, coughing up blood, a rapid or irregular heartbeat, lightheadedness, or fainting may signal a pulmonary embolism and require emergency care.
Did you know? CVR offers a DVT rule-out service for same-day or next-day diagnosis and treatment plans. Call our hotline number at 877-SCAN-DVT (877-722-6388).
Cancer can affect the body’s normal clotting system. Some tumors release substances that promote clot formation, making the blood more likely to clot.
Risk varies for everyone. According to the U.S. Centers for Disease Control and Prevention, cancers involving the pancreas, stomach, brain, lungs, uterus, ovaries, and kidneys are among those linked with higher clot risk. Certain blood cancers, including lymphoma and myeloma, can also raise risk.
Treatment can add further risk. Surgery may injure blood vessels and require reduced activity. According to the National Blood Clot Alliance, chemotherapy and some hormone therapies can affect clotting. Hospital stays and limited movement slow blood flow in the legs. Central venous catheters used for treatment can also contribute to clot formation.
Doctors also consider a previous blood clot, age, other medical conditions, and cancer activity when estimating VTE risk.
DVT prevention is individualized because not every person with cancer needs preventive blood-thinning medication. A care team weighs clot risk against bleeding risk before recommending an anticoagulant.
Hospitalized patients, people having certain cancer surgeries, and some high-risk patients receiving outpatient treatment may be candidates for preventive anticoagulation. The medication and duration depend on the clinical situation. Hematology guidance emphasizes balancing VTE prevention with bleeding risk.
Movement also matters. Regular walking and avoiding long periods of sitting can support circulation when your care team says it’s safe. During travel or recovery, ask how often you should move and whether additional precautions are appropriate.
Compression stockings may help certain patients with swelling or other vein symptoms, but they don’t replace anticoagulation when medication is medically indicated.
Anticoagulants are the main treatment for most cancer-associated DVTs. These medicines are often called blood thinners, although they don’t actually thin the blood. They reduce the blood’s ability to form and enlarge clots while the body gradually breaks the clot down.
DVT treatment may include a direct oral anticoagulant or low-molecular-weight heparin. The best choice depends on the cancer, bleeding risk, kidney function, drug interactions, platelet count, and current treatments. American Society of Hematology guidance includes both direct oral anticoagulants and low-molecular-weight heparin among treatment options for cancer-associated VTE.
More invasive treatments are reserved for selected cases. Clot-dissolving therapy or catheter-based procedures may be considered when a clot is severe. An inferior vena cava filter may be considered when anticoagulation can’t be used in a specific situation. These decisions require specialist review because cancer can increase both clotting and bleeding risks.
Contact a healthcare professional promptly if new one-sided limb swelling, pain, warmth, or discoloration develops, especially during active cancer treatment or recovery after surgery.
Call emergency services for sudden trouble breathing, chest pain, coughing up blood, fainting, or other signs of a possible pulmonary embolism. Don’t wait for a routine appointment when PE is suspected.
The relationship between DVT and cancer deserves attention, but risk can be assessed and managed. Knowing the warning signs, staying as mobile as your medical team allows, and following an individualized prevention or treatment plan can help reduce complications.
If you have concerns about leg swelling, a history of blood clots, or vein health during cancer treatment, CVR’s board-certified vein specialists can provide an expert vascular evaluation. Specialized vein care can help you understand your symptoms and make informed decisions alongside the providers managing your cancer treatment.
Schedule a consultation with Center for Vein Restoration (CVR) to receive prompt, expert evaluation in a safe outpatient setting.
Can a DVT interfere with cancer treatment?
It can. A new blood clot may require anticoagulation or changes to the timing of certain procedures, so your oncology and vascular teams should coordinate care.
Does having a DVT mean I have cancer?
No, most DVTs aren’t caused by cancer. However, an unexplained blood clot, especially one that occurs without a clear trigger, may prompt a physician to review your medical history, symptoms, and age-appropriate cancer screening to determine whether further evaluation is needed.
Should cancer survivors remain concerned about DVT after treatment ends?
Risk often changes after active treatment, but it may not disappear immediately. Ask your healthcare team how long your risk remains elevated based on your cancer history, medications, mobility, and prior clots.
About Vein Disease
Spider Veins
Varicose Veins
Vein Disease Treatments
Treating Spider Veins
Treating Varicose Veins
About Us
Patient Resources
Physician Resources
